Baudax Bio, Inc. (BXRX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	10-K	10-K
Operating expenses:
Research and development				20.1	35.6
General and administrative				27.0
Change in fair value of warrants and derivatives	0.0	-0.1	16.7
Total operating expenses	58.1	20.1	75.3	79.6
Operating loss from continuing operations	-60.8	-20.6	-59.3	-32.5	-73.5

Other expense:
Other expense, net	-2.0	-0.8	0.0	0.0	-0.1
Net income (loss)	-58.8	-19.8	-76.1	-32.6	-73.7

Per share information:

Net income (loss) per share, basic	($177.30)	($361.16)	($142.87)	($3.48)	($7.88)
Net income (loss) per share, diluted	($177.30)	($361.16)	($142.87)	($3.48)

Weighted average common shares outstanding, Basic	0.3	0.1	0.5	9.4	9.4
Weighted average common shares outstanding, Diluted	0.3	0.1	0.5	9.4